lyophilized semaglutide storage | Peptide Synthetic | High Purity GLP-1 Research Peptides — Semaglutide

TRANSCEND-T2D-1 randomized 537 patients with type 2 diabetes and inadequate glycemic control in a 1:1:1:1 ratio to receive one of three retatrutide doses (4, 9, or 12 mg) or placebo

Prior authorization and step therapy are usually required

Includes a comprehensive telehealth consult and ongoing care Highlights This Groupon is only redeemable for patients wanting to begin treatment at the starting dose of either Tirzepatide or Semaglutide

This flexibility accommodates personal preferences, comfort levels, and lifestyle factors

Clinical trials and observational studies indicate that while Ozempics GLP-1 class benefits individuals with diabetes, these drugs may also increase the risk of gallstones, a concern for patients using them primarily for weight loss

Both versions target the same mechanism, and both contain the same three strains